Recently, intratumoral CD103+ DCs have been robustly reported for their critical roles in trafficking tumor antigen to lymph nodes for both direct CD8+ T-cell stimulation and antigen transfer to resident myeloid cells (39, 40). Here, CD8A is linked to neoplasm.